Home » Topics » Regulatory » Patents

Patents
RSS

Dual 5-HT reuptake inhibitors/5-HT1A antagonists developed at Lilly

Jan. 26, 1998

Squalene synthase inhibitors patented by Pfizer

Jan. 26, 1998

SS Pharm. describes new triazoles with oral activity

Jan. 26, 1998

Laminin-related polypeptides from the University of Minnesota

Jan. 26, 1998

Ontogen describes novel MDR modulators

Jan. 23, 1998

Merck & Co. describes FPTase inhibitors with improved pharmacokinetics

Jan. 23, 1998

TNF-alpha inhibitors disclosed by Celgene

Jan. 23, 1998

New telomerase inhibitors from Geron

Jan. 23, 1998

Irreversible HIV protease inhibitors under evaluation at LG Chemical

Jan. 23, 1998

Novel bone resorption inhibitors from ADIR

Jan. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026